www.fdanews.com/articles/62091-banyu-maruho-receive-nhi-approval-for-oral-scabies-medication
BANYU, MARUHO RECEIVE NHI APPROVAL FOR ORAL SCABIES MEDICATION
August 29, 2006
Banyu Pharmaceutical and Maruho Co., Ltd. have announced that an additional indication of Stromectol Tablets 3mg -- generic name ivermectin -- has been approved for the administration for scabies treatment under the Nippon Health Insurance (NHI) system, alleviating patients' payment for the drug themselves. JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=13112)